Specialty pharmaceutical firm Eurand (EURX) agrees to be bought for $12/share in cash by Axcan...

|About: Eurand N.V. (EURX)|By:, SA News Editor

Specialty pharmaceutical firm Eurand (EURX) agrees to be bought for $12/share in cash by Axcan holdings, a pharma firm focused on gastrointestinal disorders. The $583M deal is a 9% premium to Eurand's close yesterday. (PR)